September 26, 2016 3:51 PM ET

Pharmaceuticals

Company Overview of Cadence Pharmaceuticals Inc.

Key Executives for Cadence Pharmaceuticals Inc.

NameBoard RelationshipsTitleAge
Hazel M. Aker J.D.No RelationshipsSenior Vice President, Compliance Officer, General Counsel and Secretary60
Scott A. Byrd 7 RelationshipsChief Commercial Officer and Senior Vice President46

Cadence Pharmaceuticals Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Cam L. Garner 76 RelationshipsEvoke Pharma, Inc.68
Brian G. Atwood Veracyte 192 RelationshipsCell Design Labs, Inc.63
Christopher J. Twomey 40 RelationshipsSenomyx Inc.57
Samuel L. Barker Ph.D. 51 RelationshipsLexicon Pharmaceuticals, Inc.73
C. Douglas Webb Ph.D. 31 RelationshipsCorMedix, Inc.--
View All Board Members

Cadence Pharmaceuticals Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Audit Committee Christopher J. Twomey40 Relationships3 Executives
Compensation Committee Ph.D.Samuel L. Barker51 Relationships3 Executives
Nominating Committee VeracyteBrian G. Atwood192 Relationships2 Executives
Corporate Governance Committee VeracyteBrian G. Atwood192 Relationships2 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary
409.0K
Bonus
517.0K
Total Short Term Compensation
599.6K
Total Value of Options
14.4M
Compensation as of Fiscal Year
Cadence Pharmaceuticals Inc. CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

Nouscom Announces Management Appointments
September 26, 2016 6:00 AM ET
Tyche Industries Ltd Announces the Resignation of G Sandeep as Whole Time Director and Chief Financial Officer
September 24, 2016 12:00 AM ET
Endo International plc Announces Executive Changes
September 23, 2016 11:00 AM ET
Gujarat Themis Biosyn Ltd. Announces Board Changes
September 23, 2016 10:41 AM ET
Merck KGaA Appoints Isabel De Paoli as Chief Strategy Officer, Effective 1 October 2016
September 23, 2016 12:00 AM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Cadence Pharmaceuticals Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.